Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

271 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Multiple sclerosis as an adverse effect of anti-tumor necrosis factor agents: an infrequent but important complication of infliximab in Crohn's disease].
Mir Subías A, García-López S, Sebastián Torres B, Ollero Domenche L, García Gámez A, Gomollón F. Mir Subías A, et al. Among authors: gomollon f. Gastroenterol Hepatol. 2013 Feb;36(2):81-5. doi: 10.1016/j.gastrohep.2012.07.001. Epub 2012 Dec 4. Gastroenterol Hepatol. 2013. PMID: 23218770 Spanish.
[Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis on the use of anti-tumor necrosis factor drugs in inflammatory bowel disease].
Cabriada JL, Vera I, Domènech E, Barreiro-de Acosta M, Esteve M, Gisbert JP, Panés J, Gomollón F; Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU). Cabriada JL, et al. Among authors: gomollon f. Gastroenterol Hepatol. 2013 Mar;36(3):127-46. doi: 10.1016/j.gastrohep.2013.01.002. Epub 2013 Feb 20. Gastroenterol Hepatol. 2013. PMID: 23433780 Spanish. No abstract available.
Cost-utility of biological treatment sequences for luminal Crohn's disease in Europe.
Rencz F, Gulácsi L, Péntek M, Gecse KB, Dignass A, Halfvarson J, Gomollón F, Baji P, Peyrin-Biroulet L, Lakatos PL, Brodszky V. Rencz F, et al. Among authors: gomollon f. Expert Rev Pharmacoecon Outcomes Res. 2017 Dec;17(6):597-606. doi: 10.1080/14737167.2017.1322509. Epub 2017 Apr 28. Expert Rev Pharmacoecon Outcomes Res. 2017. PMID: 28434387
Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients.
Chaparro M, Barreiro-de Acosta M, Echarri A, Almendros R, Barrio J, Llao J, Gomollón F, Vera M, Cabriada JL, Guardiola J, Guerra I, Beltrán B, Roncero O, Busquets D, Taxonera C, Calvet X, Ferreiro-Iglesias R, Ollero Pena V, Bernardo D, Donday MG, Garre A, Godino A, Díaz A, Gisbert JP. Chaparro M, et al. Among authors: gomollon f. Dig Dis Sci. 2019 Mar;64(3):846-854. doi: 10.1007/s10620-018-5362-3. Epub 2018 Nov 13. Dig Dis Sci. 2019. PMID: 30426297
271 results